Odonate Therapeutics (ODT) Announces Public Offering of Shares of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Odonate Therapeutics (ODT) Prices 5.614M Share Common Offering at $14.25/Sh
August 28, 2020 5:39 AM EDTOdonate Therapeutics, Inc. (NASDAQ: ODT) today announced the pricing of an underwritten public offering of 5,614,036 shares of its common stock, offered at a price of $14.25 per share. In addition, Odonate has granted the underwriters a 30-day option to purchase up to an additional... More
